NCCN VERSION 2 2015

147 / 188

Version 2.2015, 03/11/15 © National Comprehensive Cancer Network, Inc. 2015, All rights reserved. The NCCN Guidelines® and this illustration may not be reproduced in any form without the express written permission of NCCN®. MS-72
NCCN Guidelines Index
Breast Cancer Table of Contents
Discussion
NCCN Guidelines Version 2.2015
Breast Cancer
72. Fisher B, Costantino JP, Wickerham DL, et al. Tamoxifen for
prevention of breast cancer: report of the National Surgical Adjuvant
Breast and Bowel Project P-1 Study. J Natl Cancer Inst 1998;90:1371-
1388. Available at: .
73. Tan-Chiu E, Wang J, Costantino JP, et al. Effects of tamoxifen on
benign breast disease in women at high risk for breast cancer. J Natl
Cancer Inst 2003;95:302-307. Available at:
.
74. Allred DC, Bryant J, Land S, et al. Estrogen receptor expression as
a predictive marker of the effectiveness of tamoxifen in the treatment of
DCIS: Findings from the NSABP Protocol B-24 [abstract]. Breast
Cancer Res Treat 2002;76(Suppl 1):Abstract A30.
75. Esserman L. Integration of Imaging in the Management of Breast
Cancer. J Clin Oncol 2005;23:1601-1602. Available at:
.
76. Gundry KR. The application of breast MRI in staging and screening
for breast cancer. Oncology (Williston Park) 2005;19:159-169. Available
at:
77. Houssami N, Ciatto S, Macaskill P, et al. Accuracy and surgical
impact of magnetic resonance imaging in breast cancer staging:
systematic review and meta-analysis in detection of multifocal and
multicentric cancer. J Clin Oncol 2008;26:3248-3258. Available at:
.
78. Lehman CD, DeMartini W, Anderson BO, Edge SB. Indications for
breast MRI in the patient with newly diagnosed breast cancer. J Natl
Compr Canc Netw 2009;7:193-201. Available at:
.
79. Fischer U, Zachariae O, Baum F, et al. The influence of
preoperative MRI of the breasts on recurrence rate in patients with
breast cancer. Eur Radiol 2004;14:1725-1731. Available at:
.
80. Solin LJ, Orel SG, Hwang W-T, et al. Relationship of breast
magnetic resonance imaging to outcome after breast-conservation
treatment with radiation for women with early-stage invasive breast
carcinoma or ductal carcinoma in situ. J Clin Oncol 2008;26:386-391.
Available at: .
81. Kranick JA, Schaefer C, Rowell S, et al. Is pregnancy after breast
cancer safe? Breast J 2010;16:404-411. Available at:
.
82. Cruz MR, Prestes JC, Gimenes DL, Fanelli MF. Fertility
preservation in women with breast cancer undergoing adjuvant
chemotherapy: a systematic review. Fertil Steril 2010;94:138-143.
Available at: .
83. Dunn L, Fox KR. Techniques for fertility preservation in patients with
breast cancer. Curr Opin Obstet Gynecol 2009;21:68-73. Available at:
.
84. Oktem O, Oktay K. Fertility preservation for breast cancer patients.
Semin Reprod Med 2009;27:486-492. Available at:
.
85. Redig AJ, Brannigan R, Stryker SJ, et al. Incorporating fertility
preservation into the care of young oncology patients. Cancer
2011;117:4-10. Available at:
.
86. Lee S, Ozkavukcu S, Heytens E, et al. Value of early referral to
fertility preservation in young women with breast cancer. J Clin Oncol
2010;28:4683-4686. Available at:
.
87. Lobo RA. Potential options for preservation of fertility in women. N
Engl J Med 2005;353:64-73. Available at:
.